Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$1.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$324M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$281M |
| 4 |
DuPont de Nemours
DD
|
+$278M |
| 5 |
HCC
HCC INSURANCES HOLDINGS INC
HCC
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$830M |
| 2 |
Johnson & Johnson
JNJ
|
+$281M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$205M |
| 4 |
Bausch Health
BHC
|
+$183M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.85% |
| 2 | Technology | 3.93% |
| 3 | Financials | 3.3% |
| 4 | Energy | 3.26% |
| 5 | Communication Services | 2.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5676
CALL
AES
AES
$10.5B
| $9K | ﹤0.01% |
1,000
-6,600
| -87% | -$79.7K |
|
|
AGEN
5677
Agenus
AGEN
$312M
| $9K | ﹤0.01% |
108
+34
| +46% | +$5.03K |
|
5678
Andersons Inc
ANDE
$2.41B
| $9K | ﹤0.01% |
266
-278
| -51% | -$9.96K |
|
|
ANSS
5679
PUT
DELISTED
Ansys
ANSS
| $9K | ﹤0.01% |
+100
| New | +$9.18K |
|
5680
EyePoint Inc
EYPT
$1.03B
| $9K | ﹤0.01% |
+290
| New | +$11.4K |
|
5681
First Citizens BancShares
FCNCA
$24.9B
| $9K | ﹤0.01% |
40
-109
| -73% | -$26.7K |
|
|
FISV
5682
PUT
Fiserv Inc
FISV
$28.8B
| $9K | ﹤0.01% |
200
-1,000
| -83% | -$43.3K |
|
5683
H.B. Fuller
FUL
$2.97B
| $9K | ﹤0.01% |
263
-699
| -73% | -$26.3K |
|
5684
CALL
GATX Corp
GATX
$6.35B
| $9K | ﹤0.01% |
200
-700
| -78% | -$34.7K |
|
5685
CALL
Gildan
GIL
$10.3B
| $9K | ﹤0.01% |
+300
| New | +$9.59K |
|
5686
Genco Shipping & Trading
GNK
$1.11B
| $9K | ﹤0.01% |
+285
| New | +$17K |
|
5687
Hackett Group
HCKT
$270M
| $9K | ﹤0.01% |
635
+177
| +39% | +$2.43K |
|
5688
Helix Energy Solutions
HLX
$1.4B
| $9K | ﹤0.01% |
2,333
-1,471
| -39% | -$11.7K |
|
5689
Heron Therapeutics
HRTX
$93.9M
| $9K | ﹤0.01% |
368
-153
| -29% | -$5.1K |
|
5690
PUT
IAMGOLD
IAG
$8.2B
| $9K | ﹤0.01% |
8,500
-27,700
| -77% | -$45K |
|
5691
Integra LifeSciences
IART
$1.29B
| $9K | ﹤0.01% |
296
-900
| -75% | -$28.1K |
|
|
MITT
5692
TPG Mortgage Investment Trust
MITT
$222M
| $9K | ﹤0.01% |
203
-148
| -42% | -$7.62K |
|
5693
Strategy Inc
MSTR
$34.1B
| $9K | ﹤0.01% |
480
-1,310
| -73% | -$26K |
|
5694
CALL
Enviri
NVRI
$623M
| $9K | ﹤0.01% |
1,000
| – | – |
|
5695
Pinnacle Financial Partners Inc
PNFP
$15.9B
| $9K | ﹤0.01% |
188
-779
| -81% | -$39.4K |
|
5696
Scholastic
SCHL
$767M
| $9K | ﹤0.01% |
239
-2,572
| -91% | -$111K |
|
5697
SFL Corp
SFL
$1.64B
| $9K | ﹤0.01% |
595
-570
| -49% | -$9.3K |
|
5698
Smith & Wesson
SWBI
$651M
| $9K | ﹤0.01% |
751
-8,061
| -91% | -$105K |
|
5699
PUT
CVR Partners
UAN
$1.36B
| $9K | ﹤0.01% |
100
| – | – |
|
5700
PUT
VEON
VEON
$3.62B
| $9K | ﹤0.01% |
88
-224
| -72% | -$28K |
|
Similar funds
Barclays's Q3 2015 Portfolio in Review
As of Q3 2015, Barclays held 7,503 positions worth $82.9B, down 6.9% from $89.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $2.62B of net new capital in Q3 2015, opening 382 new positions and adding to 2,612 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, down from 6.6% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $830M trimmed.
- Barclays's largest Q3 2015 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
- Barclays added most to PRECISION CASTPARTS CORP in Q3 2015, an estimated $281M increase.
- Barclays's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $830M.
- Barclays fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $126M.
- Barclays's ten largest holdings make up 28% of its $82.9B portfolio in Q3 2015.
- Barclays opened 382 new positions and closed 515 in Q3 2015.
- Barclays's portfolio value fell 6.9% quarter-over-quarter to $82.9B.
Based on Barclays's 13F filing for Q3 2015, filed 13 Nov 2015.